Fujirebio Europe Receives Distribution Rights to Market Self-screen’s PreCursor-M+ Methylation-specific Molecular Assay, a Powerful Solution to Identify Women at High Risk for Cervical Cancer
GENT, Belgium & AMSTERDAM–(BUSINESS WIRE)–Fujirebio Europe and Self-screen B.V. today announce a commercial collaboration around the distribution of the PreCursor-M+ methylation-specific molecular IVD assay from...